BioFord
PrivateLast Round
Series A
Jun 1, 2026
Total Funding Raised
$14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioFord is a research AI platform for biology and life sciences that provides specialized AI agents for literature search, data analysis, and experimental design.
Sector
AI, Data & Cloud Infrastructure
Verticals
Biotechnology, Drug Discovery, ML Platforms, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioFord Comparables
Compare BioFord with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Purna AI | 82% | |
| BioSkepsis | 78% | |
| LatchBio | 76% |
BioFord Funding Rounds
Historical fundraising activity
BioFord Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chuangdongfang Investment | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
$14M round completed.
BioFord Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioFord's valuation, stock price, and market status.
Is BioFord a public or private company?
BioFord is a private company.
What is the current stock price of BioFord?
BioFord is a private company, so its shares have no public market price. Caplight tracks BioFord's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioFord worth (valuation)?
Valuation information for BioFord is not publicly available.
Can I buy BioFord stock?
BioFord shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioFord's last funding round?
BioFord's most recent funding round was Series A on June 1, 2026.
Who are the main investors in BioFord?
Key investors in BioFord include Chuangdongfang Investment.
Will BioFord IPO soon?
No public IPO plans have been announced for BioFord.
How can I track BioFord secondary market activity?
Caplight tracks bids, offers, and trades in BioFord's shares on secondary markets.